Detalhe da pesquisa
1.
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients.
Int J Cancer
; 146(6): 1643-1651, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31318983
2.
Impact of First Line Antiangiogenic Therapy Duration on Nivolumab Outcome in Metastatic Renal Cell Carcinoma Patients Treated in the GETUG-AFU 26 NIVOREN.
Clin Genitourin Cancer
; 21(6): 643-652, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37635052
3.
Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status.
Eur J Cancer
; 180: 21-29, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36527973
4.
Chemotherapy following immune checkpoint inhibitors in patients with locally advanced or metastatic urothelial carcinoma.
Eur J Cancer
; 175: 43-53, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36088671
5.
Cabazitaxel multiple rechallenges in metastatic castration-resistant prostate cancer.
Cancer Med
; 10(18): 6304-6309, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382352
6.
Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study.
Eur J Cancer
; 136: 76-83, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653774